C5AR1 and cancer: The receptor for complement component C5a, C5aR1, is reportedly highly expressed in a variety of cancers, including tumors of the breast (9), colon (10), and gastric (11), with high expression of C5aR1 generally associated with poor prognosis (12, 13).